Dacomitinib Treatment Followed by 3rd Generation EGFR-TKI in Patients With EGFR Mutation Positive Advanced NSCLC

Clinical trial NCT04768491 · UNKNOWN

Trial details

NCT number: NCT04768491
Sponsor: Peking Union Medical College
Status: UNKNOWN
Study type: OBSERVATIONAL

EGFR Activating Mutation NSCLC Stage IV NSCLC Stage IIIB NSCLC, Recurrent

Start date: 2020-09-01
Primary completion: 2024-06-30
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.